Holen Sie sich die Stockscreener-App
1.59
4.79%
-0.08
Handel nachbörslich:
1.62
0.03
+1.89%
Schlusskurs vom Vortag:
$1.67
Offen:
$1.68
24-Stunden-Volumen:
3.30M
Relative Volume:
0.61
Marktkapitalisierung:
$252.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-110.78M
KGV:
-1.486
EPS:
-1.07
Netto-Cashflow:
$-75.59M
1W Leistung:
-5.36%
1M Leistung:
-24.29%
6M Leistung:
+21.37%
1J Leistung:
-70.50%
1-Tages-Spanne:
$1.58
$1.68
1-Wochen-Bereich:
$1.58
$1.78
52-Wochen-Spanne:
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Firmenname
Humacyte Inc
Sektor
Branche
Telefon
919-313-9633
Adresse
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Vergleichen Sie HUMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.59 | 312.74M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Eingeleitet | Barclays | Overweight |
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-20 | Bestätigt | H.C. Wainwright | Buy |
| 2023-12-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-14 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-16 | Herabstufung | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | Eingeleitet | Cowen | Outperform |
| 2021-09-24 | Eingeleitet | Oppenheimer | Outperform |
| 2021-09-22 | Eingeleitet | BTIG Research | Buy |
| 2021-09-16 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Humacyte Inc Aktie (HUMA) Neueste Nachrichten
Market reaction to Humacyte Inc.’s recent newsTrade Performance Summary & High Win Rate Trade Alerts - newser.com
Is Humacyte Inc. stock supported by strong cash flowsMarket Activity Recap & Entry Point Confirmation Signals - newser.com
Real time pattern detection on Humacyte Inc. stockWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Can Humacyte Inc. stock reach $100 price targetEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buyingTrade Signal Summary & Capital Efficient Trading Techniques - newser.com
How to interpret RSI for Humacyte Inc. stock2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Will Humacyte Inc. stock attract more institutional investorsJuly 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFs2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Published on: 2025-11-03 03:47:12 - newser.com
Using data models to predict Humacyte Inc. Equity Warrant stock movementDollar Strength & Consistent Return Investment Signals - newser.com
Key metrics from Humacyte Inc.’s quarterly dataLayoff News & Smart Swing Trading Techniques - newser.com
Tick level data insight on Humacyte Inc. volatilityTrade Analysis Summary & Real-Time Price Movement Reports - newser.com
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday? - AOL.com
Is Humacyte Inc. stock trading near support levels2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Technical analysis overview for Humacyte Inc. Equity Warrant stockCPI Data & Advanced Technical Analysis Signals - newser.com
How Humacyte Inc. Equity Warrant stock performs in high volatility marketsEarnings Recap Report & Weekly High Conviction Ideas - newser.com
Is now a turning point for Humacyte Inc. Equity WarrantWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Predicting Humacyte Inc. trend using moving averages2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Multi asset correlation models including Humacyte Inc. Equity Warrant2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Is Humacyte Inc. Equity Warrant stock vulnerable to regulatory risksWeekly Market Report & Long Hold Capital Preservation Tips - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Earnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakoutQuarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
Chart overlay techniques for tracking Humacyte Inc.July 2025 Snapshot & Community Verified Trade Alerts - newser.com
What recovery options are there for Humacyte Inc. Equity Warrant2025 Price Momentum & Low Drawdown Momentum Trade Ideas - newser.com
Will Humacyte Inc. stock benefit from infrastructure spendingWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Is Humacyte Inc. Equity Warrant stock a dividend growth opportunityJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Earnings visualization tools for Humacyte Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Will Humacyte Inc. stock deliver shareholder valueJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Humacyte rises on Symvess sale to military treatment facility - MSN
Why Humacyte Inc. stock remains on buy listsMarket Trend Summary & High Accuracy Swing Trade Signals - newser.com
Why Humacyte Inc. Equity Warrant stock could outperform in 2025July 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
Historical volatility pattern of Humacyte Inc. Equity Warrant visualized2025 Buyback Activity & Target Return Focused Picks - newser.com
Tick level data insight on Humacyte Inc. Equity Warrant volatilityWatch List & Momentum Based Trading Ideas - newser.com
Using RSI to spot recovery in Humacyte Inc. Equity WarrantWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Finanzdaten der Humacyte Inc-Aktie (HUMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):